UBX domain protein 8 (UBXD8) is a member of the UBX domain-containing protein family, which is characterized by the presence of the UBX domain, a conserved sequence motif that plays a role in protein-protein interactions. This domain is involved in the modulation of a variety of cellular processes, including vesicular trafficking, membrane fusion, and ubiquitin-related events.UBXD8 is involved in the regulation of lipid metabolism and has been implicated in the maintenance of endoplasmic reticulum (ER) homeostasis. It participates in the ER-associated degradation (ERAD) pathway, which is responsible for the identification and disposal of misfolded proteins from the ER. UBXD8 is capable of recognizing misfolded proteins within the ER and signaling for their retrotranslocation to the cytosol where they are subsequently ubiquitinated and degraded by the proteasome.
One of the notable functions of UBXD8 is its role in the regulation of lipid droplet biogenesis and lipid storage. It interacts with the triglyceride synthesis enzyme diacylglycerol acyltransferase 2 (DGAT2), influencing triglyceride synthesis and the formation of lipid droplets. Through this interaction, UBXD8 may serve as a key player in lipid homeostasis and energy metabolism.UBXD8 also plays a role in the cellular response to lipid overload. When cells are overloaded with fatty acids, UBXD8 can inhibit the activity of the fatty acid channel, FATP1, reducing the influx of fatty acids into the ER and helping to prevent lipotoxicity.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
Disrupts ER to Golgi transport, potentially affecting UBXD8's role in ER-associated degradation. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
A proteasome inhibitor, could indirectly affect UBXD8's involvement in ERAD by altering proteasomal degradation pathways. | ||||||
Tunicamycin | 11089-65-9 | sc-3506A sc-3506 | 5 mg 10 mg | $172.00 $305.00 | 66 | |
Induces ER stress by inhibiting N-linked glycosylation, potentially impacting UBXD8-related pathways. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
A SERCA pump inhibitor that causes ER stress, which might indirectly influence UBXD8's function in ERAD. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
Known to disrupt lysosomal function, potentially affecting pathways where UBXD8 is involved. | ||||||
Sodium phenylbutyrate | 1716-12-7 | sc-200652 sc-200652A sc-200652B sc-200652C sc-200652D | 1 g 10 g 100 g 1 kg 10 kg | $77.00 $166.00 $622.00 $5004.00 $32783.00 | 43 | |
Acts as a chemical chaperone, potentially modulating ER stress and indirectly affecting UBXD8 activity. | ||||||
Nexturastat A | 1403783-31-2 | sc-478176 | 1 mg | $330.00 | ||
Specifically inhibits Vps34, a class III PI3K, potentially affecting autophagic processes linked with UBXD8 function. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Inhibits PI3K, which could indirectly influence pathways where UBXD8 is involved. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
An mTOR inhibitor, could indirectly affect UBXD8 by modulating autophagy and lipid metabolism pathways. | ||||||